Overexpression of nuclear protein kinase CK2 α catalytic subunit (CK2α) as a poor prognosticator in human colorectal Cancer

Kai Yuan Lin, Chein Tai, Jung Chin Hsu, Chien Feng Li, Chia Lang Fang, Hsi Chin Lai, You Cheng Hseu, Yi Feng Lin, Yih Huei Uen

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Background: Colorectal cancer (CRC) is one of the most common malignancies but the current therapeutic approaches for advanced CRC are less efficient. Thus, novel therapeutic approaches are badly needed. The purpose of this study is to investigate the involvement of nuclear protein kinase CK2 α subunit (CK2α) in tumor progression, and in the prognosis of human CRC. Methodology/Principal Findings: Expression levels of nuclear CK2α were analyzed in 245 colorectal tissues from patients with CRC by immunohistochemistry, quantitative real-time PCR and Western blot. We correlated the expression levels with clinicopathologic parameters and prognosis in human CRC patients. Overexpression of nuclear CK2α was significantly correlated with depth of invasion, nodal status, American Joint Committee on Cancer (AJCC) staging, degree of differentiation, and perineural invasion. Patients with high expression levels of nuclear CK2α had a significantly poorer overall survival rate compared with patients with low expression levels of nuclear CK2α. In multi-variate Cox regression analysis, overexpression of nuclear CK2α was proven to be an independent prognostic marker for CRC. In addition, DLD-1 human colon cancer cells were employed as a cellular model to study the role of CK2α on cell growth, and the expression of CK2α in DLD-1 cells was inhibited by using siRNA technology. The data indicated that CK2α-specific siRNA treatment resulted in growth inhibition. Conclusions/Significance: Taken together, overexpression of nuclear CK2α can be a useful marker for predicting the outcome of patients with CRC.

Original languageEnglish
Article numbere17193
JournalPLoS One
Volume6
Issue number2
DOIs
Publication statusPublished - 2011

Fingerprint

Casein Kinase II
nuclear proteins
protein subunits
Nuclear Proteins
colorectal neoplasms
protein kinases
Small Interfering RNA
Colorectal Neoplasms
Catalytic Domain
Cell growth
Regression analysis
Tumors
Cells
Tissue
small interfering RNA
prognosis
Neoplasm Staging
therapeutics
neoplasms
Growth

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Overexpression of nuclear protein kinase CK2 α catalytic subunit (CK2α) as a poor prognosticator in human colorectal Cancer. / Lin, Kai Yuan; Tai, Chein; Hsu, Jung Chin; Li, Chien Feng; Fang, Chia Lang; Lai, Hsi Chin; Hseu, You Cheng; Lin, Yi Feng; Uen, Yih Huei.

In: PLoS One, Vol. 6, No. 2, e17193, 2011.

Research output: Contribution to journalArticle

Lin, Kai Yuan ; Tai, Chein ; Hsu, Jung Chin ; Li, Chien Feng ; Fang, Chia Lang ; Lai, Hsi Chin ; Hseu, You Cheng ; Lin, Yi Feng ; Uen, Yih Huei. / Overexpression of nuclear protein kinase CK2 α catalytic subunit (CK2α) as a poor prognosticator in human colorectal Cancer. In: PLoS One. 2011 ; Vol. 6, No. 2.
@article{d8baa98768334b6186c0de289c70e4f6,
title = "Overexpression of nuclear protein kinase CK2 α catalytic subunit (CK2α) as a poor prognosticator in human colorectal Cancer",
abstract = "Background: Colorectal cancer (CRC) is one of the most common malignancies but the current therapeutic approaches for advanced CRC are less efficient. Thus, novel therapeutic approaches are badly needed. The purpose of this study is to investigate the involvement of nuclear protein kinase CK2 α subunit (CK2α) in tumor progression, and in the prognosis of human CRC. Methodology/Principal Findings: Expression levels of nuclear CK2α were analyzed in 245 colorectal tissues from patients with CRC by immunohistochemistry, quantitative real-time PCR and Western blot. We correlated the expression levels with clinicopathologic parameters and prognosis in human CRC patients. Overexpression of nuclear CK2α was significantly correlated with depth of invasion, nodal status, American Joint Committee on Cancer (AJCC) staging, degree of differentiation, and perineural invasion. Patients with high expression levels of nuclear CK2α had a significantly poorer overall survival rate compared with patients with low expression levels of nuclear CK2α. In multi-variate Cox regression analysis, overexpression of nuclear CK2α was proven to be an independent prognostic marker for CRC. In addition, DLD-1 human colon cancer cells were employed as a cellular model to study the role of CK2α on cell growth, and the expression of CK2α in DLD-1 cells was inhibited by using siRNA technology. The data indicated that CK2α-specific siRNA treatment resulted in growth inhibition. Conclusions/Significance: Taken together, overexpression of nuclear CK2α can be a useful marker for predicting the outcome of patients with CRC.",
author = "Lin, {Kai Yuan} and Chein Tai and Hsu, {Jung Chin} and Li, {Chien Feng} and Fang, {Chia Lang} and Lai, {Hsi Chin} and Hseu, {You Cheng} and Lin, {Yi Feng} and Uen, {Yih Huei}",
year = "2011",
doi = "10.1371/journal.pone.0017193",
language = "English",
volume = "6",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "2",

}

TY - JOUR

T1 - Overexpression of nuclear protein kinase CK2 α catalytic subunit (CK2α) as a poor prognosticator in human colorectal Cancer

AU - Lin, Kai Yuan

AU - Tai, Chein

AU - Hsu, Jung Chin

AU - Li, Chien Feng

AU - Fang, Chia Lang

AU - Lai, Hsi Chin

AU - Hseu, You Cheng

AU - Lin, Yi Feng

AU - Uen, Yih Huei

PY - 2011

Y1 - 2011

N2 - Background: Colorectal cancer (CRC) is one of the most common malignancies but the current therapeutic approaches for advanced CRC are less efficient. Thus, novel therapeutic approaches are badly needed. The purpose of this study is to investigate the involvement of nuclear protein kinase CK2 α subunit (CK2α) in tumor progression, and in the prognosis of human CRC. Methodology/Principal Findings: Expression levels of nuclear CK2α were analyzed in 245 colorectal tissues from patients with CRC by immunohistochemistry, quantitative real-time PCR and Western blot. We correlated the expression levels with clinicopathologic parameters and prognosis in human CRC patients. Overexpression of nuclear CK2α was significantly correlated with depth of invasion, nodal status, American Joint Committee on Cancer (AJCC) staging, degree of differentiation, and perineural invasion. Patients with high expression levels of nuclear CK2α had a significantly poorer overall survival rate compared with patients with low expression levels of nuclear CK2α. In multi-variate Cox regression analysis, overexpression of nuclear CK2α was proven to be an independent prognostic marker for CRC. In addition, DLD-1 human colon cancer cells were employed as a cellular model to study the role of CK2α on cell growth, and the expression of CK2α in DLD-1 cells was inhibited by using siRNA technology. The data indicated that CK2α-specific siRNA treatment resulted in growth inhibition. Conclusions/Significance: Taken together, overexpression of nuclear CK2α can be a useful marker for predicting the outcome of patients with CRC.

AB - Background: Colorectal cancer (CRC) is one of the most common malignancies but the current therapeutic approaches for advanced CRC are less efficient. Thus, novel therapeutic approaches are badly needed. The purpose of this study is to investigate the involvement of nuclear protein kinase CK2 α subunit (CK2α) in tumor progression, and in the prognosis of human CRC. Methodology/Principal Findings: Expression levels of nuclear CK2α were analyzed in 245 colorectal tissues from patients with CRC by immunohistochemistry, quantitative real-time PCR and Western blot. We correlated the expression levels with clinicopathologic parameters and prognosis in human CRC patients. Overexpression of nuclear CK2α was significantly correlated with depth of invasion, nodal status, American Joint Committee on Cancer (AJCC) staging, degree of differentiation, and perineural invasion. Patients with high expression levels of nuclear CK2α had a significantly poorer overall survival rate compared with patients with low expression levels of nuclear CK2α. In multi-variate Cox regression analysis, overexpression of nuclear CK2α was proven to be an independent prognostic marker for CRC. In addition, DLD-1 human colon cancer cells were employed as a cellular model to study the role of CK2α on cell growth, and the expression of CK2α in DLD-1 cells was inhibited by using siRNA technology. The data indicated that CK2α-specific siRNA treatment resulted in growth inhibition. Conclusions/Significance: Taken together, overexpression of nuclear CK2α can be a useful marker for predicting the outcome of patients with CRC.

UR - http://www.scopus.com/inward/record.url?scp=79951983174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951983174&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0017193

DO - 10.1371/journal.pone.0017193

M3 - Article

VL - 6

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 2

M1 - e17193

ER -